Neurol. praxi. 2018;19(5):335-337 | DOI: 10.36290/neu.2018.116

Methods of neurostimulation in the treatment of headaches

MUDr. Jana Múdra, MUDr. Silvia Petričková
Neurologická klinika UNLP a LF UPJŠ v Košiciach

Headache is one of the most common neurological symptoms and may have many causes. According to the ICHD-3 (The InternationalClassification of Headache Disorders 3rd edition), they are divided into three groups: primary headaches, secondaryheadaches, and painful cranial neuropathy and other facial pain and headaches. Pharmacological treatment of primary headachesis often difficult, insufficient and ineffective, and often carries various side effects. Recently, neurostimulation methods involvingnon-invasive and mini-invasive techniques, as well as deep brain stimulation, are used in patients with chronic primary headaches,which is used primarily in the treatment of chronic resistant cluster headache.

Keywords: headache, neurostimulation, migraine, side effects

Published: October 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Múdra J, Petričková S. Methods of neurostimulation in the treatment of headaches. Neurol. praxi. 2018;19(5):335-337. doi: 10.36290/neu.2018.116.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Barbanti P, Grazzi L, Egeo G, Padovan AM, Liebler E, Bussone G. Non-invasive vagus nerve stimulation for acute treatment of high-frequency and chronic migraine: an open-label study. J Headache Pain 2015; 16: 61. Go to original source... Go to PubMed...
    2. Bhola R, Kinsella E, Giffin N, Lipscombe S, Ahmed F, Weatherall M, Goadsby PJ. Single-pulse transcranial magnetic stimulation (sTMS) for the acute treatment of migraine: evaluation of outcome data for the UK post market pilot program. J Headache Pain 2015; 16: 51. Go to original source... Go to PubMed...
    3. Binfalah M, Al-Ghawi E, Shosha E, Al-Hilly A, Bakhiet M. Sphenopalatine ganglion block for the treatment of acute migraine. Pain Research and Treatment 2018; 90: 144. Go to original source... Go to PubMed...
    4. Bittar RG, Kar-Purkayastha I, Owen SL, Bear RE, Green A, Wang S, Aziz TZ. Deep brain stimulation for pain relief: a meta-analysis. Journal of Clinical Neuroscience 2005; 12(5): 515-519. Go to original source... Go to PubMed...
    5. Black RD, Rogers LL, Ade KK, Nicoletto HA, Adkins HD, Laskowitz DT. Non-invasive neuromodulation using time-varying caloric vestibular stimulation. IEEE journal of translational engineering in health and medicine 2016; 4: 1-10. Go to original source... Go to PubMed...
    6. Fontaine D, Santucci S, Lanteri-Minet M. Managing cluster headache with sphenopalatine ganglion stimulation: a review. Journal of Pain Research 2018; 11: 375-381. Go to original source... Go to PubMed...
    7. Fontaine D, Lazorthes Y, Mertens P, Blond S, Géraud G, Fabre N, Navez M, Lucas CH, Dubois F, Gonfrier S, Paquis P, Lantori-Minet M. Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension. The journal of headache and pain 2010; 11(1): 23. Go to original source... Go to PubMed...
    8. Fontaine D, Vandersteen C, Magis D, Lanteri-Minet M. Neuromodulation in cluster headache. Adv Tech Stand Neurosurg. 2015; 42: 321. Go to original source... Go to PubMed...
    9. Huotarinen A, Kallela M, Artto V, Laakso A, Kivisaari R. Deep brain stimulation of posterior hypothalamic area for cluster headache: A retrospective case series. Cephalalgia Reports 2018; 1: 1-5. Go to original source...
    10. Jenkins B, Tepper SJ. Neurostimulation for primary headache disorders: part 2, review of central neurostimulators for primary headache, overall therapeutic efficacy, safety, cost, patient selection, and future research in headache neuromodulation. Headache 2011; 51: 1408-1418. Go to original source... Go to PubMed...
    11. Jűrgens TP, Barloese M, May A, Láinez JM, Schoenen J, Gaul C, Goodman AM, Caparso A, Jensen RH. Long-term effectiveness of sphenopalatine ganglion stimulation for cluster headache. Cephalalgia 2016; 37(5): 423-434. Go to original source... Go to PubMed...
    12. Leone M, May A, Franzini G, Broggi D, Dodick A, Rapoport PJ, Goadsby J, Schoenen V, Bonavita G, Bussone G. Deep brain stimulation for intractable chronic cluster headache: proposals for patient selection. Cephalalgia 2004; 24(11): 934-937. Go to original source... Go to PubMed...
    13. Leone M, Proietti Cecchini A. Deep brain stimulation in headache. Cephalalgia 2016; 36: 1143-1148. Go to original source... Go to PubMed...
    14. Lambru G, Matharu M. Peripheral neurostimulation in primary headaches. Neurol Sci. 2014; 35: 77-81. Go to original source... Go to PubMed...
    15. Magis D, Jensen R, Schoenen J. Neurostimulation therapies for primary headache disorders: present and future. Curr Opin Neurol. 2012; 25: 269-276. Go to original source... Go to PubMed...
    16. Magis D, Schoenen J. Advances and challenges in neurostimulation for headaches. Lancet Neurol. 2012; 11: 708-719. Go to original source... Go to PubMed...
    17. Saper JR, Dodick DW, Silberstein SD, McCarville S, Sun M, Goadsby PJ. Occipital nerve stimulation for the treatment of intractable chronic migraine headache: ONSTIM feasibility study. Cephalalgia 2011; 31: 271-285. Go to original source... Go to PubMed...
    18. Schoenen J, Jensen RH, Lanteri-Minet M, Lainez MJA, Gaul C, Goodman AM, Caparso A, May A. Stimulation of the sphenopalatine ganglion (SPG) for cluster headache treatment. Pathway CH-1: a randomized, sham-controlled study. Cephalalgia 2013; 33(10): 816-830. Go to original source... Go to PubMed...
    19. Schoenen J, Vandersmissen B, Jeangette S, Herroelen L, Vandenheede M, Gérard P, Magis D. Migraine prevention with a supraorbital transcutaneous transcutaneous stimulator: a randomized controlled trial. Neurology 2013; 80: 697-704. Go to original source... Go to PubMed...
    20. Schwedt TJ, Vargas B. Neurostimulation for treatment of migraine and cluster headache. Pain Medicine 2015; 16: 1827-1834. Go to original source... Go to PubMed...
    21. Starling AJ, Tepper SJ, Marmura MJ, Shamim EA, Robbins MS, Hndiyeh N, Charles AC, Goadsby PJ, Lipton RB, Silberstein SD, Gelfand AA, Chiacchierini RP, Dodick DW. A multicenter, prospective, single arm, open label, observational study of sTMS for migraine prevention (ESPOUSE Study). Cephalalgia 2018; 38(6): 1038-1048. Go to original source... Go to PubMed...
    22. Wilkinson D, Ade KK, Rogers LL, Attix DK, Kuchibhatla M, Slade MD, Smith LL, Poynter KP, Laskowitz DT, Freeman MC, Hoffer ME, Saper JR, Scott DL, Sakel M, Calhoun AH, Black RD. Preventing episodic migraine with caloric vestibular stimulation: a randomized controlled trial. Headache: The Journal of Head and Face Pain 2017; 57: 1065-1087. Go to original source... Go to PubMed...
    23. Woolf C, Thompson J. Segmental afferent fiber-induced analgesia: Transcutaneous electrical nerve stimulation (TENS) and vibration. In: Melzack R, Wall P, editors. Textbook of Pain. 2nd ed. Edinburgh: Churchill-Livingstone. 1994: 884-896.

    Return to the content


    Neurology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.